Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors
Clinical trial NCT03611595 · COMPLETED
Trial details
- NCT number
- NCT03611595
- Sponsor
- Peter Zage
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-28
- Primary completion
- 2026-02-24
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.